MAY 24, 2022 9:00 AM PDT

A cGMP Compatible, Non-Viral CAR T Cell Manufacturing Process

Sponsored by: MaxCyte
Speaker

Abstract
Date:  May 24, 2022
Time: 9:00am (PDT),  12:00pm (EDT), 6:00pm (CEST)
 
Recent breakthroughs in autologous cellular therapies have generated tremendous excitement for the industry; however, these advances have been confronted with the expense of manufacturing of viral gene delivery and concerns over random integration and the safety of viral vectors. To combat these challenges, researchers at the University of California San Francisco have developed a novel system that offers lower toxicity with a single-stranded DNA (ssDNA) approach. UCSF scientists used MaxCyte ExPERT technology as a non-viral alternative that allows for site-specific delivery of transgenes through homology-directed repair (HDR) to circumvent complex and expensive manufacturing. This approach resulted in highly efficient knock-in integration efficiencies (46-62%) and yields of1.5 x 109 CAR+ T cells, well above current adoptive cellular therapy doses. The groundbreaking experiments discussed during this event demonstrate the ability of the MaxCyte GTx™ to deliver ssCTS HDR templates and CRISPR-Cas9 RNP to modify T cells in clinically relevant amounts.
 
Learning Objectives
  • Outline large-scale, non-viral manufacturing for engineered CAR T cells
  • Demonstrate 5-fold boosted knock-in and >7-fold increased live cell yields relative to dsDNA approaches
  • Reveal MaxCyte GTx™ delivery of ssCTS HDR templates and CRISPR-Cas9 RNP to modify T cells for a future clinical setting
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
APR 20, 2022 11:00 AM PDT
APR 20, 2022 11:00 AM PDT
Date: April 20, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) As novel therapeutic modalities progress through development, improved analytical techniques are required to overcome co...
Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds